Cervical cancer has the fourth-highest mortality rate among cancers in women and is also the fourth most common cancer in women worldwide. Every seven minutes a woman in India dies from cervical cancer, resulting in over 75,000 deaths per year. India alone accounts for 20% of all cervical cancer cases worldwide. Telangana is ranked no. 3 for cervical cancer cases, after stomach cancer and breast cancer. Due to a lack of personal hygiene & routine screening programs, in both rural and urban population, women often seek care far too late when cancer has become invasive and is untreatable. “India could be cervical cancer-free by 2079 with accessible prevention programmes such as the human papillomavirus (HPV) vaccine and cervical screening more accessible,” Lancet Study.
Why screening for cervical cancer is important in India?
What are cervical cell changes that are detected in cervical cancer screening?
Who should go for cervical cancer screening?
What are the screening options for cervical cancer?
What are the screening recommendations for the early detection of cervical cancer?
What are the treatment options for precancerous cervical lesions?
What are the treatment options for cervical cancer?
Can cervical cancer be prevented?
Does HPV vaccination show benefit in preventing cervical cancer?
Cervical cancer is an abnormal growth of cells in the lining of the cervix or the cylinder-shaped neck of tissue that connects the vagina and uterus of a woman.
In most cases, cancer presents in the area of the cervix known as the transformation zone. However, it may also spread to neighboring tissues of the cervix like the vagina or even to the distant organs within the body, such as the liver or the lung. Cervical cancer is treatable and curable if detected early.
India bears a significant burden of cervical cancer among women. Two major reasons for this high burden are:
Presumptive testing for the presence of pre-cancer or cancer among asymptomatic or apparently healthy women is called cervical cancer screening. Early detection of pre-cancerous lesions is beneficial since it is easier to treat it at this stage and even avoid cancer altogether. Early screening not only benefits in case of precancerous lesions but also helps in early detection of cancer in an early stage. Treatment of cancer in early stages is highly amenable to cure.
Precursor lesions which are otherwise invisible to the naked eye, lead to cancer of the cervix over a period of time. It is possible to diagnose these precursor lesions by a special investigation known as cervical cytology. The lesions progress in a slow manner, sometimes taking as long as 10 – 20 years before assuming an invasive form.
The World Health Organization (WHO) recommends that cervical cancer should be approached in an all-inclusive comprehensive way for its effective prevention and control. The strategy should include components of:
Vaccination of girls in the age group of 9-13 years against Human Papilloma Virus (HPV) at the onset of reproductive activity is the primary mode of prevention of cervical cancer. In addition to this, other recommended interventions for prevention include engaging young boys and girls for:
Creating awareness about the harmful effects of tobacco since it is an important risk factor for cervical cancer and youngsters often get habituated to it
Sexually active women should be screened for abnormal cervical cells and pre-cancerous lesions, starting from 30 years of age. Women between 30-49 years are at the highest risk of developing the disease, therefore should be targeted for screening.
If treatment is needed to excise abnormal cells or lesions, cryotherapy i.e destroying abnormal tissue on the cervix by freezing is recommended. If signs of cervical cancer are present, treatment options include surgery, radiotherapy and chemotherapy.
Precursor lesions of cervical cancer have been proven to be of a milder degree in case of younger women under 30 years of age. It has also been substantiated with evidence that these low-grade lesions revert back to normalcy after a certain period of time in such cases. On the other hand, this rate of reversal or regression to normalcy decreases in elderly women. The lesions in older women have a higher chance of progression to high-grade precursors and eventually to cervical cancer. The average age of patients with high-grade cervical cancer or squamous intraepithelial lesion (SIL) is around 30 years and the average timespan of the progression of the precursor lesions to cancer is approximately 10 years. A slow development period of the precursor gives an opportunity to diagnose the disease early.
Screening programmes can successfully achieve their aim by:
Cells of the cervix, known as squamous cells and glandular cells appear abnormal on examination with a microscope in presence of precancerous changes. The abnormal changes within the cells of the cervical tissue even though not cancer may eventually lead to cancer.
Human papillomavirus (HPV) of certain types cause cervical cell changes. An association between cervical malignancy and HPV infection has been scientifically established. In more than 90% of cases of cervical squamous carcinomas, carcinomas in situ and adenocarcinoma HPV DNA is identified.
One of the major challenges with HPV is that it has a very hard structure making it stable and difficult to eliminate by sterilizing instruments. HPV also possesses a relatively high resistance to agents like ether and acids.
Cervical cell changes are of two main types:
In many commonly identified cervical precancerous lesions, the abnormal changes are noticed in the squamous cells and the glandular cells.
The Bethesda system is a newer type of classification wherein, the precursors are termed as squamous intra-epithelial lesions (SIL). These are further divided into two different types, namely the low-grade SIL that is similar to Cervical intraepithelial neoplasia (CIN I) and the high-grade SIL similar to Cervical intraepithelial neoplasia (CIN II and CIN III).
High-grade abnormalities usually do not cause symptoms, but they have a high probability of developing into cervical cancer within a span of 10 to 15 years if not detected and treated early. Any such changes if observed should undergo further testing. High-grade abnormalities necessarily need to undergo treatment.
Since a majority of cervical cancer cases in India are reported after 30 years of age, the Federation of Obstetric and Gynaecological Societies of India (FOGSI) recommends that healthcare settings with adequate resources should begin screening at 25 years and those with fewer resources should begin screening at 30 years.
The common screening options include:
The Pap test has the potential to identify abnormal cells in the cervix that are suspected to turn into cancer. In the HPV(human papillomavirus) test the causative virus for cell changes is identified. Pap tests are useful in the early detection of cervical cancer. When diagnosed in this stage, the chances of complete cure of the cancer are quite high.
While HPV testing is considered to be the best available method, other screening tests i.e HPV, cytology, combined testing with both HPV and cytology, and VIA, are considered to be valid options for screening.
The general recommendations for screening for cervical cancer are as under:
In certain cases, women with specific health history like HIV infection, organ transplant, exposure to Diethylstilbestrol (DES) etc may require an individualized screening schedule for cervical cancer. Women with such a history should definitely consult their doctor.
In women tested positive for the presence of a precancerous cervical lesion, certain treatment options are available that can help reduce the chances of the conversion of the lesion into cervical cancer. Some of these treatment options include:
The treatment options for cervical cancer are undergoing rapid improvisations. With many options now available, the most suitable choice for an individual will depend on several factors like:
Fertility-sparing surgery is often a preferred treatment option for women with early cervical cancer. Fertility issues for younger women are high on our list of considerations and we make an endeavor to provide support for all women undergoing sexual side effects consequential to cervical cancer treatment through our survivorship support program.
As mentioned before, the type and stage of cervical cancer and other factors like a person’s health, age, and sensitivity to certain medications etc determine the suitable treatment option for cervical cancer. Some of the treatment options that may be used independently or in combination include:
The use of medications to destroy cancer cells is called chemotherapy. Advanced cervical cancer is treated with a therapy known as concurrent chemoradiation which is essentially a combination of chemotherapy with radiation therapy. Chemo augments the effect of the radiation.
This entails making use of drugs that act specifically on cancer cells, leaving aside the normal cells. The cancer cells are selectively destroyed. The underlying principle of targeted therapy is that it identifies and counteracts some unique characteristics of specific cancer cells. The drugs in targeted therapy attach to the receptor proteins of the cancer cells. This property aids in either killing the cells or augmenting other therapies like chemotherapy to work more effectively. Angiogenesis inhibitors are drugs used in targeted therapy that primarily prevent the development of blood vessels by cancer cells that feed tumors.
Immunotherapy makes use of the body’s own immune system in fighting against the disease. Certain drugs which stimulate the immune system to fight specific cancer cells are used in this therapy. Currently, certain such drugs for the treatment of melanoma, kidney and/or lung cancers, have been approved. Clinical trials on a variety of other cancers are underway. It is anticipated that a combination of immunotherapies with other treatments is likely to improve outcomes for some patients.
High-powered energy beams are used to destroy cancer cells. Radiosurgery is an advanced treatment option, also known as stereotactic body radiotherapy. Here intense radiation is used instead of surgery for the removal of cancerous tissues.
Hysterectomy or surgical removal of the uterus, Cervicectomy or surgical removal of the cervix, with or without removal of lymph nodes, cryosurgery & cervical conization are some of the surgical options for treating cervical cancer.
It is possible to remove only the affected tissue by the gynecologist if a woman wishes to preserve her fertility. However, this may not be always possible, especially in cases with more complex diseases. Fertility-sparing procedures should be discussed with the doctor before beginning the personalized treatment plan.
Intended to improve the quality of life of cancer patients with the terminal disease who may not be amenable to treatment.
Even though eliminating the complete risk of cervical cancer may not be possible, certain preventive measures can be taken:
Primary Prevention:
Healthy lifestyle choices should be made alongside creating a conducive environment that assists individuals in making healthy choices. Women should:
Human papillomavirus and other sexually transmitted diseases should be prevented from spreading by using barrier methods during intercourse.
Undergo family planning to avoid many children as giving birth more than once or multiparity, is also associated with a higher risk for cervical cancer and HPV infection.
Secondary prevention:
The objective of secondary prevention is early detection and treatment of precursor lesions. Cervical cancer is preventable. Federation of Obstetric and Gynaecological Societies of India (FOGSI) endorses the recommendation of the World Health Organization (WHO) that in the preferred age group of under 15 years, two doses of vaccination can be administered at an interval of 6 months for primary prevention. The vaccination charts by WHO also lay down the recommendations for older girls, women and special cases. It is reiterated that screening should not be discontinued after vaccination.
Primary prevention for cervical cancer with the HPV vaccine is strongly recommended.
Infection control related to the Human Papilloma Virus (HPV): The strong association between cervical malignancy and HPV infection has been established scientifically. As mentioned earlier, Sexually transmitted HPV infection is thought to cause the majority of cervical cancers. In more than 90% of cervical carcinomas in situ, squamous carcinomas, and adenocarcinoma, HPV DNA is isolated.
“The risk of HPV and other sexually transmitted infections remains a factor should your risk status change — for example, a new partner, or any illness which suppresses your immune system,” Dr. Nikhil S Ghadyalpatil
When comparing HPV test and Pap test, a negative HPV test indicates a far lower risk for cervical cancer and greater assurance of low cervical cancer risk than a negative Pap test.
HPV vaccination in young girls and young women is shown to be of benefit when administered:
About Author –
Dr. Nikhil S Ghadyalpatil, Consultant Medical Oncologist, Yashoda Hospitals – Hyderabad
MD, DNB, DM (Medical Oncology)
Dr. Nikhil S Ghadyalpatil has more than 8 years of experience and has specialized in chemotherapy, targeted therapy and immunotherapy and bone marrow transplantation for solid and blood malignancies.
Heart failure, also called congestive heart failure, is a condition that arises when the muscles…
Percutaneous Transluminal Coronary Angioplasty, or PTCA, is a minimally invasive surgery that opens blocked or…
Ankle ligaments are crucial cords that link foot bones to lower leg bones, ensuring stability…
Supermarkets today are flooded with a variety of cooking oils, each with different characteristics, such…
మాట్లాడటానికి, తినటానికి మరియు ముఖం అందంగా కనిపించటానికి నోరే కీలకం. శరీర పోషణకు అవసరమైన ఆహారం, పానీయాలు లోపలికి చేరేది…
అండాశయ తిత్తులు అనేవి అండాశయాల లోపల లేదా వాటి ఉపరితలంపై ద్రవంతో నిండిన సంచి లాంటి నిర్మాణాలు. ఆడవారికి రెండు…